433 related articles for article (PubMed ID: 19152222)
1. Cardiomyocytes derived from human embryonic stem cells - characteristics and utility for drug discovery.
Steel D; Hyllner J; Sartipy P
Curr Opin Drug Discov Devel; 2009 Jan; 12(1):133-40. PubMed ID: 19152222
[TBL] [Abstract][Full Text] [Related]
2. The application of human embryonic stem cell technologies to drug discovery.
Sartipy P; Björquist P; Strehl R; Hyllner J
Drug Discov Today; 2007 Sep; 12(17-18):688-99. PubMed ID: 17826681
[TBL] [Abstract][Full Text] [Related]
3. Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery.
Braam SR; Passier R; Mummery CL
Trends Pharmacol Sci; 2009 Oct; 30(10):536-45. PubMed ID: 19762090
[TBL] [Abstract][Full Text] [Related]
4. [Embryonic stem cells in pharmacology].
Laustriat D; Gide J; Héchard C; Peschanski M
Med Sci (Paris); 2009 May; 25 Spec No 2():32-8. PubMed ID: 19848191
[TBL] [Abstract][Full Text] [Related]
5. Generation of cardiomyocytes from new human embryonic stem cell lines derived from poor-quality blastocysts.
Raya A; Rodríguez-Pizà I; Arán B; Consiglio A; Barri PN; Veiga A; Izpisúa Belmonte JC
Cold Spring Harb Symp Quant Biol; 2008; 73():127-35. PubMed ID: 19028986
[TBL] [Abstract][Full Text] [Related]
6. Human embryonic stem cells for cardiomyogenesis.
Habib M; Caspi O; Gepstein L
J Mol Cell Cardiol; 2008 Oct; 45(4):462-74. PubMed ID: 18775434
[TBL] [Abstract][Full Text] [Related]
7. Generation of human embryonic stem cell-derived mesoderm and cardiac cells using size-specified aggregates in an oxygen-controlled bioreactor.
Niebruegge S; Bauwens CL; Peerani R; Thavandiran N; Masse S; Sevaptisidis E; Nanthakumar K; Woodhouse K; Husain M; Kumacheva E; Zandstra PW
Biotechnol Bioeng; 2009 Feb; 102(2):493-507. PubMed ID: 18767184
[TBL] [Abstract][Full Text] [Related]
8. Human embryonic stem cells: current technologies and emerging industrial applications.
Améen C; Strehl R; Björquist P; Lindahl A; Hyllner J; Sartipy P
Crit Rev Oncol Hematol; 2008 Jan; 65(1):54-80. PubMed ID: 17689256
[TBL] [Abstract][Full Text] [Related]
9. Cardiomyocytes derived from human pluripotent stem cells for drug screening.
Zeevi-Levin N; Itskovitz-Eldor J; Binah O
Pharmacol Ther; 2012 May; 134(2):180-8. PubMed ID: 22269465
[TBL] [Abstract][Full Text] [Related]
10. The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells.
Yokoo N; Baba S; Kaichi S; Niwa A; Mima T; Doi H; Yamanaka S; Nakahata T; Heike T
Biochem Biophys Res Commun; 2009 Sep; 387(3):482-8. PubMed ID: 19615974
[TBL] [Abstract][Full Text] [Related]
11. Embryonic stem cells as a novel cell source of cell-based biosensors.
Liu Q; Huang H; Cai H; Xu Y; Li Y; Li R; Wang P
Biosens Bioelectron; 2007 Jan; 22(6):810-5. PubMed ID: 16621504
[TBL] [Abstract][Full Text] [Related]
12. Prospects for pluripotent stem cell-derived cardiomyocytes in cardiac cell therapy and as disease models.
Freund C; Mummery CL
J Cell Biochem; 2009 Jul; 107(4):592-9. PubMed ID: 19449339
[TBL] [Abstract][Full Text] [Related]
13. Preclinical assessment of cardiac toxicity.
Kettenhofen R; Bohlen H
Drug Discov Today; 2008 Aug; 13(15-16):702-7. PubMed ID: 18602016
[TBL] [Abstract][Full Text] [Related]
14. Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach.
Sartiani L; Bettiol E; Stillitano F; Mugelli A; Cerbai E; Jaconi ME
Stem Cells; 2007 May; 25(5):1136-44. PubMed ID: 17255522
[TBL] [Abstract][Full Text] [Related]
15. Cardiomyocytes.
Yang X; Guo XM; Wang CY; Tian XC
Methods Enzymol; 2006; 418():267-83. PubMed ID: 17141041
[TBL] [Abstract][Full Text] [Related]
16. Determinants of pluripotency: from avian, rodents, to primates.
Martins-Taylor K; Xu RH
J Cell Biochem; 2010 Jan; 109(1):16-25. PubMed ID: 19937733
[TBL] [Abstract][Full Text] [Related]
17. Cardiomyocyte differentiation of human induced pluripotent stem cells.
Zwi L; Caspi O; Arbel G; Huber I; Gepstein A; Park IH; Gepstein L
Circulation; 2009 Oct; 120(15):1513-23. PubMed ID: 19786631
[TBL] [Abstract][Full Text] [Related]
18. Cardiomyocyte differentiation of pluripotent stem cells and their use as cardiac disease models.
Dambrot C; Passier R; Atsma D; Mummery CL
Biochem J; 2011 Feb; 434(1):25-35. PubMed ID: 21269276
[TBL] [Abstract][Full Text] [Related]
19. Stem cells for drug screening.
Laposa RR
J Cardiovasc Pharmacol; 2011 Sep; 58(3):240-5. PubMed ID: 21499120
[TBL] [Abstract][Full Text] [Related]
20. Impacts of recent advances in cardiovascular regenerative medicine on clinical therapies and drug discovery.
Murata M; Tohyama S; Fukuda K
Pharmacol Ther; 2010 May; 126(2):109-18. PubMed ID: 20156482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
